EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Site‐specifically radiolabeled nanobodies for imaging blood‐brain barrier penetration and targeting in the brain

Yingbo Li, Junfeng Wang iD

Journal of Labelled Compounds and Radiopharmaceuticals · 2023-12 · 66 (14) · 444-451

DOI: 10.1002/jlcr.4069 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Labelled Compounds and Radiopharmaceuticals, online erschienen am 24.10.2023. Verfasst von Yingbo Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China. Hauptthemen laut MEDLINE: Single-Domain Antibodies. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanobodies (Nbs) hold significant potential in molecular imaging due to their unique characteristics. However, there are challenges to overcome when it comes to brain imaging. To address these obstacles, collaborative efforts and interdisciplinary research are needed. This article aims to raise awareness and encourage collaboration among researchers from various fields to find solutions for effective brain imaging using Nbs. By fostering cooperation and knowledge sharing, we can make progress in overcoming the existing limitations and pave the way for improved molecular imaging techniques in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Single-Domain AntibodiesBlood-Brain BarrierMolecular Imaging

Stichwörter der Autor:innen

BBB penetrationbrain disordermolecular imagingnanobodysite-specific labeling

Substanzen

Single-Domain Antibodies

Autor:innen und Institutionen

  • State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China.
  • Gordon Center for Medical Imaging, Massachusetts General Hospital & Department of Radiology, Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Junfeng Wang

Förderung

  • NIA NIH HHS
  • National Institutes of Health

Zitieren

APA

Li, Y., & Wang, J. (2023). Site‐specifically radiolabeled nanobodies for imaging blood‐brain barrier penetration and targeting in the brain. Journal of Labelled Compounds and Radiopharmaceuticals, 66(14), 444-451. https://doi.org/10.1002/jlcr.4069

Vancouver

Li Y, Wang J. Site‐specifically radiolabeled nanobodies for imaging blood‐brain barrier penetration and targeting in the brain. Journal of Labelled Compounds and Radiopharmaceuticals. 2023;66(14):444-451. doi:10.1002/jlcr.4069

BibTeX
@article{Li2023,
  author = {Li, Yingbo and Wang, Junfeng},
  title = {Site‐specifically radiolabeled nanobodies for imaging blood‐brain barrier penetration and targeting in the brain},
  journal = {Journal of Labelled Compounds and Radiopharmaceuticals},
  year = {2023},
  volume = {66},
  number = {14},
  pages = {444--451},
  doi = {10.1002/jlcr.4069}
}
Kostenlos starten →